![](https://endpts.com/wp-content/uploads/2023/04/AACR-2023-tile.jpg)
#AACR23 (Photo: Nicole DeFeudis for Endpoints News)
AACR roundup: Merus eyes accelerated approval; Immuneering accelerates RAS drug
Merus offered an interim look at an ongoing Phase I/II trial for its bispecific antibody petosemtamab on Monday, showing an overall …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.